Join to view full profile
600 Highland AveMadison, WI 53792
Phone+1 608-265-1700
Dr. Kenkre is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2007 - 2010
Tufts Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
WI State Medical License 2010 - 2027
IL State Medical License 2007 - 2014
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification PRISM, IOD Incorporated, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma Start of enrollment: 2016 Mar 10
Publications & Presentations
PubMed
- Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas.Victoria Anne Gill, Thomas A Ollila, Urmi Ghosh, Narendranath Epperla, Lindsey A Fitzgerald
Blood Advances. 2026-09-24 - Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.Sanjal H Desai, Susan M Geyer, Levi Pederson, Michael A Spinner, Veronika Bachanova
Blood Cancer Journal. 2026-06-25 - 2 citationsAmerican Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.Sairah Ahmed, Ambuj Kumar, Paul Carpenter, Alex Herrera, Kara Kelly
Transplantation and Cellular Therapy. 2026-03-01
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center AnalysisVaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
UW Study Provides Potential Treatment Strategy for Aggressive LymphomaJune 12th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: